Pfizer says it will seek clearance in September for its vaccine to be used in children aged 2 to 11. by BY EMILY ANTHES

The company said it also plans to apply this month for full F.D.A. approval — not just emergency authorization — for the vaccine’s use in adults.

Published: May 4, 2021 at 08:34PM

from NYT Health